Since 2024, the dRPC has been supporting Sight and Life’s formative work to landscape the Multiple Micronutrient Supplementation (MMS) policy, fiscal, and product markets as it supports the Nigerian government’s rollout and eventual scale-up.

In 2021, Nigeria’s Honourable Minister of Health’s Ministerial Order approving the use of MMS during pregnancy kickstarted a process, effectively permitting a transition from Iron–Folic Acid Supplementation (IFAS) to MMS as the standard for antenatal care. This decision, embedded in the updated 2021 National Guidelines for the Prevention and Control of Micronutrient Deficiencies in Nigeria, was grounded in the World Health Organisation’s 2020 recommendations on antenatal care.

Under the next administration, which assumed office in 2023, the government has demonstrated a clear practice of advancing MMS through targeted transition actions absent a transition plan. In January 2024, the Honourable Minister of Health and Social Welfare reaffirmed the transition from IFAS to MMS for pregnant women. MMS has been included in the National Essential Medicines List, enabling public procurement and aligning with cost-effectiveness standards. By the 17th of December 2025, during the 2025 Biennial National Micronutrient Conference, the government launched further policy thrusts, including its Roadmap for Scaling MMS (2025–2029), alongside the Micronutrient Supplementation Landscape Analysis Report and the Nutrition in Emergencies Strategy. The National Plan of Action for Food and Nutrition also incorporate MMS, while investments in local manufacturing, supported by the Presidential Initiative for Unlocking the Healthcare Value Chain, aim to ensure sustainable supply.

This partnership will support the Federal Ministry of Health and Social Welfare in achieving its Roadmap for Scaling MMS.